BEONE MEDICINES LTD. (BEIGF) Gross margin 2016–2025
BEONE MEDICINES LTD. (BEIGF) gross margin by fiscal year — reported gross profit divided by reported revenue.
87.5%FY2025 · since FY2016: 100.0% → 87.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 87.5% | +3.1 pp |
| FY2024 | 84.4% | -0.1 pp |
| FY2023 | 84.5% | +4.8 pp |
| FY2022 | 79.8% | -6.2 pp |
| FY2021 | 86.0% | +8.9 pp |
| FY2020 | 77.1% | -6.3 pp |
| FY2019 | 83.4% | -2.1 pp |
| FY2018 | 85.5% | -12.4 pp |
| FY2017 | 97.9% | -2.1 pp |
| FY2016 | 100.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More BEIGF financial trends
BEIGF RevenueBEIGF Net incomeBEIGF Net marginBEIGF Gross profitBEIGF Operating incomeBEIGF Operating marginBEIGF Operating cash flowBEIGF Free cash flowBEIGF Capital expendituresBEIGF Return on equityBEIGF Stock buybacksBEIGF Dividends paidBEIGF Total assetsBEIGF Total liabilitiesBEIGF Shareholders’ equityBEIGF overview →